Dylan Crossey: Pre-inquest hearing today after CPS decide not to pursue driver for manslaughter
A spokesman for the CPS last year said all evidence has been looked at.He said:"The evidence, including evidence called at the inquest has been carefully re-considered and our prosecutors determined our legal test was not met. Our thoughts remain with the family of Dylan Crossey.
The pre-inquest review will take place at County Hall, Bow Lane, Preston, from 10am on Friday, December 2. It is listed for half a day.David Harwood of New Longton was previously prosecuted for causing death by dangerous driving and in the alternative causing death by careless driving, but was acquitted following a submission that there was no case to answer for either offence.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Dylan Dreyer is glowing as she shares very happy update on TodayToday star Dylan Dreyer was glowing in a new series of photos posted on Instagram as she shared a happy update on the NBC daytime program
Læs mere »
Noel Gallagher's High Flying Birds pre sale for homecoming showTickets go on sale next week for the north west gig
Læs mere »
Eurostar security staff to strike during busy pre-Christmas travel periodEurostar security staff to strike during busy pre-Christmas travel period ⚠️ The RMT Union claims services will be ‘severely’ affected by the strike action over four days in December
Læs mere »
SpaceX grounds Falcon 9 carrying first private lunar landerLift-off postponed for 'additional pre-flight checkouts'
Læs mere »
A Cross-Sectional and Longitudinal Analysis of Pre-Diagnostic Blood Plasma Biomarkers for Early Detection of Pancreatic CancerPancreatic ductal adenocarcinoma (PDAC) is a major cause of cancer death that typically presents at an advanced stage. No reliable markers for early detection presently exist. The prominent tumor stroma represents a source of circulating biomarkers for use together with cancer cell-derived biomarkers for earlier PDAC diagnosis. CA19-9 and CEA (cancer cell-derived biomarkers), together with endostatin and collagen IV (stroma-derived) were examined alone, or together, by multivariable modelling, using pre-diagnostic plasma samples (n=259 samples) from the Northern Sweden Health and Disease Study biobank. Serial samples were available for a subgroup of future patients. Marker efficacy for future PDAC case prediction (n=154 future cases) was examined by both cross-sectional (ROC analysis) and longitudinal analyses. CA19-9 performed well at, and within, six months to diagnosis and multivariable modelling was not superior to CA19-9 alone in cross-sectional analysis. Within six months to diagnosis, CA19-9 (AUC=0.92) outperformed the multivariable model (AUC=0.81) at a cross-sectional level. At diagnosis, CA19-9 (AUC=0.995) and the model (AUC=0.977) performed similarly. Longitudinal analysis revealed increases in CA19-9 up to two years to diagnosis which indicates a window of opportunity for early detection of PDAC.
Læs mere »